A medium dose of CTX induces IFN-I-dependent modulation of dendritic and T cells in vivo and suppresses tumor growth in a CD8+ T cell-dependent manner in several murine models, including its curative effect on advanced EO771 breast cancer, as demonstrated in this study. Here, CD8A is linked to neoplasm.